Redeye updates its estimates and valuation following Vitec releasing its Q3 2023 report. Recurring revenues and margins exceeded our estimates, while non-recurring revenues came in below what we had pencilled in. We make limited changes to our estimates and valuation, and our view of Vitec’s investment case remains unchanged.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases